Services-Medical Laboratories
Personalis, Inc. (PSNL) stock: what's happening now, every material event decoded in plain English, P/E and valuation, analyst ratings, and insider buying and selling.
AllSight quality score: 27/100 — a percentile rank of Personalis, Inc.’s fundamentals against Services peers.
Is Personalis, Inc. overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.
Consensus: Buy from 12 analysts (Buy 9 · Hold 3).
Average price target: $14.95 (−8.2% vs $16.28); range $9–$17.
Wall Street analyst consensus, shown as context — not an AllSight view.
Open-market buys: 14 · Open-market sells: 73 · Net: +$19.4M
Discretionary open-market purchases are the signal; grants, option exercises and Rule 10b5-1 scheduled trades are context, not counted in the balance. Facts only — not a recommendation. Source: SEC Form 4 filings on EDGAR.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.